Dr Reddy's Laboratories announced on Saturday that the United States Food and Drug Administration (USFDA) has issued a Form 483 with two observations following an inspection of its API (Active…
Hyderabad based pharma giant Dr. Reddy’s laboratories firmly rejected media reports claiming that the company major is slashing workforce related costs by 25 per cent.The company’s response came after media…
Axis Securities has downgraded Hindustan Unilever to ‘hold’ rating with a target price of Rs 2,520 (+8%). Analysts expect near-term challenges for the company to persist with subdued demand in…
NEW DELHI: Dr Reddy's Laboratories on Thursday said its consolidated net profit increased 2 per cent to Rs 1,413 crore in the third quarter ended December 31, 2024 driven by…
Aurigene Oncology lab (Picture credit: Aurigene Oncology Limited) HYDERABAD: Dr Reddy’s Laboratories’ wholly-owned subsidiary, Aurigene Oncology Limited, has received Drugs Controller General of India (DCGI) approval for conducting a phase-2…
Dr Reddy’s Laboratories HYDERABAD: Dr Reddy’s Laboratories and Hetero are among half a dozen generic drug makers to have entered into non-exclusive, royalty-free voluntary licencing agreements with Gilead Sciences Ireland…
HYDERABAD: Pharma biggie Dr Reddy’s Laboratories has injected a little over Rs 734 crore in in Dr Reddy’s and Nestle Health Science Limited, its newly incorporated joint venture company with…
HYDERABAD: Despite clocking its highest ever quarterly revenues, higher tax outgo pulled down Hyderabad-based pharma major Dr Reddy’s Laboratories’ consolidated net profit for the first quarter ended June 30, 2024,…